Portal Innovations
VC · Chicago · United States
Stages
Investment region
Industries
Profile
Portal Innovations is a venture capital firm based in Chicago, Illinois, founded in 2020. The firm specializes in supporting life sciences, medtech, and bioinformatics startups by providing seed capital, lab space, and management expertise. Portal Innovations operates with a team of 30 professionals and has a presence in multiple locations, including Chicago, Providence, and New Brunswick. The firm focuses on investing in early-stage companies, particularly in the life sciences and healthcare sectors. It typically supports Series A and seed-stage startups, primarily in the United States, with some investments in Australia. Portal Innovations manages the Velocity Fund, which has an AUM of $100 million, launched in 2025. Notable portfolio companies include Moonlight Therapeutics - clinical trials, Syntax Bio - drug discovery, CrossBridge Bio - acquired by Eli Lilly, Syntis Bio - drug discovery, and March Biosciences - drug discovery. These investments highlight Portal Innovations' commitment to advancing scientific breakthroughs in the biotech and healthcare industries.
Contatos (2)
| Name | Title | Telefone | ||
|---|---|---|---|---|
| Founder & CEO | — | — | — | |
| Director of Business Development | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.